CA983919A - Steroid compounds - Google Patents

Steroid compounds

Info

Publication number: CA983919A
Authority: CA; Canada
Prior art keywords: steroid compounds; steroid; compounds
Prior art date: 1971-07-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Inventor

Gordon H. Phillipps

Alan F. English

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Laboratories Ltd

Original Assignee

Glaxo Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-07-05

Filing date

1972-07-04

Publication date

1976-02-17

1972-07-04Application filed by Glaxo Laboratories LtdfiledCriticalGlaxo Laboratories Ltd

1976-02-17Application grantedgrantedCritical

1976-02-17Publication of CA983919ApublicationCriticalpatent/CA983919A/en

StatusExpiredlegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA146,248A1971-07-051972-07-04Steroid compoundsExpiredCA983919A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB3134971AGB1391443A (en)	1971-07-05	1971-07-05	Ester of betamethasone and its 9alpha-chloro analogue

Publications (1)

Publication Number	Publication Date
CA983919Atrue CA983919A (en)	1976-02-17

Family

ID=10321802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA146,248AExpiredCA983919A (en)	1971-07-05	1972-07-04	Steroid compounds

Country Status (17)

Country	Link
JP (1)	JPS5644079B1 (en)
AR (2)	AR194120A1 (en)
AU (1)	AU464251B2 (en)
BE (1)	BE785812A (en)
CA (1)	CA983919A (en)
CH (1)	CH609065A5 (en)
DE (1)	DE2232827A1 (en)
DK (1)	DK131474B (en)
FR (1)	FR2144761B1 (en)
GB (1)	GB1391443A (en)
IE (1)	IE36529B1 (en)
IL (1)	IL39821A (en)
NL (1)	NL169882C (en)
NO (1)	NO137754C (en)
PH (1)	PH13195A (en)
SE (1)	SE385904B (en)
ZA (1)	ZA724598B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8207151B2 (en)	2008-05-28	2012-06-26	Validus Biopharma Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US9198921B2 (en)	2010-04-05	2015-12-01	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en)	2015-06-29	2020-10-13	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en)	2019-03-07	2022-07-12	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5024427A (en)*	1973-01-03	1975-03-15
SE418294B (en)*	1974-03-27	1981-05-18	Plurichemie Anstalt	SET TO MAKE A 16ALFA- OR 16BETA-9ALFA-CHLORINE OR FLUOROSTEROID ESTER
JPS6163976U (en)*	1984-10-01	1986-05-01

0
- BEBE785812Dpatent/BE785812A/ennot_activeIP Right Cessation
1971
- 1971-07-05GBGB3134971Apatent/GB1391443A/ennot_activeExpired
1972
- 1972-07-04IEIE939/72Apatent/IE36529B1/enunknown
- 1972-07-04CACA146,248Apatent/CA983919A/ennot_activeExpired
- 1972-07-04ILIL39821Apatent/IL39821A/enunknown
- 1972-07-04DKDK331372AApatent/DK131474B/enunknown
- 1972-07-04ARAR242889Apatent/AR194120A1/enactive
- 1972-07-04NLNLAANVRAGE7209345,Apatent/NL169882C/ennot_activeIP Right Cessation
- 1972-07-04SESE7208817Apatent/SE385904B/enunknown
- 1972-07-04AUAU44205/72Apatent/AU464251B2/ennot_activeExpired
- 1972-07-04CHCH1003472Apatent/CH609065A5/ennot_activeIP Right Cessation
- 1972-07-04JPJP6640472Apatent/JPS5644079B1/jaactivePending
- 1972-07-04NONO2406/72Apatent/NO137754C/enunknown
- 1972-07-04FRFR7224132Apatent/FR2144761B1/frnot_activeExpired
- 1972-07-04ZAZA724598Apatent/ZA724598B/enunknown
- 1972-07-04DEDE2232827Apatent/DE2232827A1/ennot_activeCeased
- 1972-07-05PHPH13687Apatent/PH13195A/enunknown
1973
- 1973-05-21ARAR248131Apatent/AR194553A1/enactive

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10857161B2 (en)	2008-05-28	2020-12-08	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-kB for treatment of disease
US8334279B2 (en)	2008-05-28	2012-12-18	Validus Genetics	Non-hormonal steroid modulators of NF-κB for treatment of disease
US8673887B2 (en)	2008-05-28	2014-03-18	Reveragen Biopharma, Inc	Non-hormonal steroid modulators of NF-kB for treatment of disease
US8207151B2 (en)	2008-05-28	2012-06-26	Validus Biopharma Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US9434758B2 (en)	2008-05-28	2016-09-06	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US9649320B2 (en)	2008-05-28	2017-05-16	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US11833159B2 (en)	2008-05-28	2023-12-05	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-kB for treatment of disease
US10206933B2 (en)	2008-05-28	2019-02-19	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-kB for treatment of disease
US9198921B2 (en)	2010-04-05	2015-12-01	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US10000525B2 (en)	2010-04-05	2018-06-19	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en)	2015-06-29	2020-10-13	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11690853B2 (en)	2015-06-29	2023-07-04	Reveragen Biopharma, Inc.	Non-hormonal steroid modulators of NF-κβ for treatment of disease
US11382922B2 (en)	2019-03-07	2022-07-12	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en)	2019-03-07	2022-10-18	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions
US12201639B2 (en)	2019-03-07	2025-01-21	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number	Publication date
FR2144761A1 (en)	1973-02-16
NO137754C (en)	1978-04-19
IE36529B1 (en)	1976-11-24
SE385904B (en)	1976-07-26
AR194553A1 (en)	1973-07-23
JPS5644079B1 (en)	1981-10-16
NL169882B (en)	1982-04-01
DK131474C (en)	1975-12-08
FR2144761B1 (en)	1976-03-05
ZA724598B (en)	1973-03-28
NL169882C (en)	1982-09-01
CH609065A5 (en)	1979-02-15
NO137754B (en)	1978-01-09
IL39821A0 (en)	1972-09-28
PH13195A (en)	1980-01-18
BE785812A (en)	1973-01-04
IL39821A (en)	1976-02-29
AU464251B2 (en)	1975-08-21
DE2232827A1 (en)	1973-01-18
IE36529L (en)	1973-01-05
NL7209345A (en)	1973-01-09
AR194120A1 (en)	1973-06-22
DK131474B (en)	1975-07-21
AU4420572A (en)	1974-01-10
GB1391443A (en)	1975-04-23

Publication	Publication Date	Title
AU473868B2 (en)	1976-07-08	Steroid compounds
CA1017336A (en)	1977-09-13	Divinyl-diphenyl compounds
AU459132B2 (en)	1975-02-26	Etrachlorophthalide compounds
AU466025B2 (en)	1975-01-09	Aminohalopyridyloxy compounds
CA1026346A (en)	1978-02-14	Triazolyphosphorus compounds
CA1006163A (en)	1977-03-01	Arylaminopyridine compounds
CA981269A (en)	1976-01-06	3-carbamoyl-4-phenyl-quinoline compounds
AU466453B2 (en)	1973-12-20	Triaszolothienodiazepine compounds
CA977345A (en)	1975-11-04	Perfluoroalkyl-phosphorus compounds
AU464251B2 (en)	1975-08-21	Steroid compounds
CA955929A (en)	1974-10-08	Steroids
CA983946A (en)	1976-02-17	Disilyl-containing compounds
CA1019871A (en)	1977-10-25	Arc- and track - resistant polyepoxide - polysiloxane compounds
CA1001641A (en)	1976-12-14	Polyhalobenzylic disulfooxonium compounds
CA989389A (en)	1976-05-18	Steroids
CA869995A (en)	1971-05-04	Steroidal compounds
CA879680A (en)	1971-08-31	Cyclopropyl-substituted steroids
CA869996A (en)	1971-05-04	Steroids
CA873333A (en)	1971-06-15	Steroid derivatives
CA880332A (en)	1971-09-07	Steroid analogs
AU471594B2 (en)	1976-04-29	Oxichromic compounds
CA879704A (en)	1971-08-31	Triazinylaminocoumarin compounds
AU451849B2 (en)	1974-08-02	Sulfinyl-and sulfonylpyridine compounds
CA861533A (en)	1971-01-19	N-propargyl-pyridinium compounds
CA866216A (en)	1971-03-16	Gem-difluoramino compounds

Movatterモバイル変換